Kimiko Sogabe
Tokushima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Immune deficiency/dysregulation-associated lymphoma with an immunophenotype resembling EBV-positive nodal T/NK-cell lymphoma during treatment of follicular lymphoma
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: June 03, 2026
Novel noninvasive parameters for diagnosis of liver involvement in patients with systemic AL amyloidosis.
Journal: International journal of hematology
Published: June 24, 2025
False-Positive Galactomannan Test Results in Multiple Myeloma.
Journal: Diseases (Basel, Switzerland)
Published: March 09, 2025
Effective Intractable Chylous Ascites Treatment by Lymphangiography with Lipiodol in a Patient with Follicular Lymphoma.
Journal: Internal medicine (Tokyo, Japan)
Published: September 29, 2024
Preparedness for the future in patients with relapsed or refractory hematopoietic malignancies in the treatment process: a qualitative study.
Journal: Annals of palliative medicine
Published: September 10, 2024
Quality of skeletal muscles during allogeneic stem-cell transplantation: a pilot study.
Journal: BMJ supportive & palliative care
Published: July 03, 2024
Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interaction.
Journal: Cancer science
Published: June 04, 2024
Skeletal muscle mass during chemotherapy for haematological malignancies: a retrospective study.
Journal: BMJ supportive & palliative care
Published: March 06, 2024
Toxoplasmic encephalitis with high 201Tl uptake and retention mimicking malignant lymphoma in a patient with human immunodeficiency virus infection.
Journal: Parasitology international
Published: February 14, 2024
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid.
Journal: International journal of hematology
Published: November 22, 2023
Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.
Journal: International journal of hematology
Published: August 12, 2023
Last Updated: 09/26/2026